Atrial Fibrillation Market Will Climb Above USD 14.8 Billion in 2019 : Transparency Market Research

354 views

Published on

Transparency Market Research published new market report" Atrial Fibrillation Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 ". The global market for atrial fibrillation was valued at USD 6.1 billion in 2012 and it is expected to reach an estimated value of USD 14.8 billion in 2019, growing at a CAGR of 13.4% from 2013 to 2019.Atrial fibrillation is a type of cardiac arrhythmia distinguished by an abnormal cardiac rhythm caused by a disturbance in heart’s electrical system. Atrial fibrillation (AF) is one of the most commonly occurring cardiac rhythm conditions. Being a potentially life threatening disease and expensive to treat, the overall healthcare system views the treatment for this condition as a strategically critical area to address. This report analyzes the market for atrial fibrillation market from the point of view of various pharmacological and non-pharmacological treatment products used for the treatment of AF.

Browse the report With Full TOC at http://www.transparencymarketresearch.com/atrial-fibrillation-market.html

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
354
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
3
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Atrial Fibrillation Market Will Climb Above USD 14.8 Billion in 2019 : Transparency Market Research

  1. 1. Transparency Market Research Atrial Fibrillation Market Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 Buy Now Request Sample Published Date: Oct 2013 Single User License: US $ 4795 Multi User License: US $ 7795 88 Pages Report Corporate User License: US $ 10795 REPORT DESCRIPTION Atrial Fibrillation Market is Expected to Reach USD 14.8 Billion Globally in 2019: Transparency Market Research Transparency Market Research is Published new Market Report “Atrial Fibrillation Market (Pharmacological and Non-Pharmacological Treatment, Electric Cardioversion, Radiofrequency, Cryo, Laser and Microwave Catheter Ablation, Maze Surgery, AntiCoagulant and Anti-Arrhythmic Drugs) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," . The global market for atrial fibrillation was valued at USD 6.1 billion in 2012 and it is expected to reach an estimated value of USD 14.8 billion in 2019, growing at a CAGR of 13.4% from 2013 to 2019. Rising global base of geriatric population inducing an accelerated growth in the incidence rates of atrial fibrillation is one of the highest impact-rendering drivers for this market. In addition, favorable results exhibited by clinical trials promoting combined pharmacological therapy such as the HARMONY trial and rising prevalence of disorders causing atrial fibrillation such as hypertension and obesity will also serve the market as drivers. The future growth of this market will be ensured by the introduction of advanced treatment procedures such as hybrid ablation and the rising prevalence of atrial fibrillation in emerging Asian economies.
  2. 2. On account of the fact that pharmacological treatment procedures are more frequently administered to the patients suffering from atrial fibrillation and are a cheaper alternative to non-pharmacological procedures, pharmacological procedures held the majority of market share in 2012. With the introduction of new drugs such as Bristol Myer Squibb's NTC-801, Merck's Vernakalant, Boehringer Ingelheim's Pradaxa, the market share of pharmacological treatment procedures is expected to further increase by 2019. The non-pharmacological treatment market was led by the catheter ablation market and its market share was valued at over 45% in 2012. The introduction of new catheter ablation systems such as CardioFocus's HeartLight Endoscopic Ablation System (EAS) laser ablation catheter, Endosense's TactiCath and Biosense Webster's ThermoCool SmartTouch, will help the catheter ablation market to further enhance its market share by 2019. The radiofrequency based catheter ablation treatment for atrial fibrillation market led the catheter ablation market in terms of market share in 2012 majorly on account of the facts that it has a relatively lower procedural duration and cost and has high success rates associated with it. High prevalence of atrial fibrillation coupled with the availability of high disposable incomes amongst patients and sophisticated healthcare infrastructure, has led the North American atrial fibrillation market to hold the majority of the market share in 2012. However, this region is expected to lose its market share to relatively faster growing Asia-Pacific region. Some of the key players of this market include Boehringer Ingelheim, Bristol-Myers Squibb/Pfizer, Bayer/Johnson & Johnson, Medtronic, Inc., St. Jude Medical, Inc. and AtriCure, Inc. The global atrial fibrillation market is categorized into the following segments:  Atrial Fibrillation Market, by Treatment Types o Pharmacological Treatment   o Anti-Arrhythmic Drugs Anti-Coagulant Drugs Non-Pharmacological Treatment  Catheter Ablation  Radiofrequency Based  Cryoablation Based  HIFU (High Intensity Focused Ultrasound) Based
  3. 3.  Microwave Based  Laser Based    Maze Surgery Electric Cardioversion Atrial Fibrillation Market, by Geography o North America o Europe o Asia-Pacific o Rest of the World (RoW) TABLE OF CONTENTS Chapter 1 Preface 1.1 Report description 1.2 Market segmentation 1.3 Research methodology Chapter 2 Executive Summary Chapter 3 Market Overview 3.1 Introduction 3.2 Market Dynamics 3.2.1 Drivers 3.2.1.1 Rising global base of geriatric population 3.2.1.2 Favorable results exhibited by clinical trials aimed at treating atrial fibrillation 3.2.1.3 Rising prevalence of disorders such as hypertension and obesity accelerating the incidence rate of atrial fibrillation 3.2.2 Restraints
  4. 4. 3.2.2.1 Stringent FDA, CE and European Medicines Agency product approval regulations 3.2.3 Opportunities 3.2.3.1 Introduction of innovative treatment procedures 3.2.3.2 Rising prevalence of atrial fibrillation in emerging Asian economies 3.3 Porter’s Five Forces Analysis for the Global Atrial Fibrillation Market 3.3.1 Bargaining Power of Suppliers 3.3.2 Bargaining Power of Buyers 3.3.3 Threat of Substitutes 3.3.4 Threat of New Entrants 3.3.5 Competitive Rivalry Browse the full report with Complete TOC at http://www.transparencymarketresearch.com/atrial-fibrillation-market.html Chapter 4 Atrial Fibrillation Market, by Treatment Types 4.1 Overview 4.1.1 Global Atrial Fibrillation Market, 2011 – 2019 (USD Million) 4.2 Global Pharmacological Treatments for Atrial Fibrillation Market 4.2.1 Global Pharmacological Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million) 4.2.2 Global Anti-Arrhythmic Drugs Market 4.2.2.1 Global Anti-Arrhythmic Drugs Market, 2011 – 2019 (USD Million) 4.2.3 Global Anti-Coagulants Market 4.2.3.1 Global Anti-Coagulant Drugs for Atrial Fibrillation Market, 2011 – 2019 (USD Million) 4.3 Non-Pharmacological Treatment for Atrial Fibrillation Market
  5. 5. 4.3.1 Overview: Comparative Analysis of the Non-Pharmacological Treatment for Atrial Fibrillation Market 4.3.2 Global Non-Pharmacological Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million) 4.3.3 Global Catheter Ablation Treatment for Atrial Fibrillation Market 4.3.3.1 Overview 4.3.3.2 Global Catheter Ablation Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million) 4.3.3.3 Global Radiofrequency Based Catheter Ablation Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million) 4.3.3.4 Global HIFU (High Intensity Focused Ultrasound) Based Catheter Ablation Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million) 4.3.3.5 Global Cryoablation Based Catheter Ablation Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million) 4.3.3.6 Global Microwave Based Catheter Ablation Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million) 4.3.3.7 Global Laser Based Catheter Ablation Treatment for Atrial Fibrillation Market, 2011 – 2019 (USD Million) 4.3.4 Global Maze Surgery for Atrial Fibrillation Market, 2011 – 2019 (USD Million) 4.3.5 Global Electric Cardioversion for Atrial Fibrillation Market, 2011 – 2019 (USD Million) Chapter 5 Atrial Fibrillation Market, by Geography 5.1 Overview 5.2 North America 5.2.1 North America Atrial Fibrillation Market, by Treatment Types, 2011 – 2019 (USD Million) 5.3 Europe 5.3.1 Europe Atrial Fibrillation Market, by Treatment Types, 2011 – 2019 (USD Million)
  6. 6. 5.4 Asia-Pacific 5.4.1 Asia-Pacific Atrial Fibrillation Market, by Treatment Types, 2011 – 2019 (USD Million) 5.5 Rest of the World (RoW) 5.5.1 RoW Atrial Fibrillation Market, by Treatment Types, 2011 – 2019 (USD Million) Related & Recently Published Reports by Transparency Market Research  Transcriptomics Technologies Market: http://www.transparencymarketresearch.com/transcriptomicstechnologies-market.html  Freeze Drying Equipment Market: http://www.transparencymarketresearch.com/freeze-dryingequipment-market.html  Metal Cans Market: http://www.transparencymarketresearch.com/metalcans-market.html Chapter 6 Competitive Landscape Chapter 7 Recommendations 7.1 Investing in emerging markets, particularly China and Brazil 7.2 Focus on emerging technologies such as mini-maze procedure and catheter ablation Chapter 8 Company Profiles 8.1 AtriCure, Inc. 8.1.1 Company Overview 8.1.2 Financial Overview 8.1.3 Product Portfolio 8.1.4 Business Strategies 8.2 Biosense Webster, Inc. 8.2.1 Company Overview
  7. 7. 8.2.2 Product Portfolio 8.2.3 Business Strategies 8.3 Boehringer Ingelheim GmbH 8.3.1 Company Overview 8.3.2 Financial Overview 8.3.3 Product Portfolio 8.3.4 Business Strategies 8.3.5 Recent Developments 8.4 Boston Scientific Corporation 8.4.1 Company Overview 8.4.2 Financial Overview 8.4.3 Product Portfolio 8.4.4 Business Strategies 8.5 Bristol-Myers Squibb Corporation 8.5.1 Company Overview 8.5.2 Financial Overview 8.5.3 Product Portfolio 8.5.4 Business Strategies 8.6 CardioFocus, Inc. 8.6.1 Company Overview 8.6.2 Product Portfolio 8.7 Endoscopic Technologies, Inc. 8.7.1 Company Overview 8.7.2 Product Portfolio 8.7.3 Business Strategies
  8. 8. 8.8 Sanofi Aventis 8.8.1 Company Overview 8.8.2 Financial Overview 8.8.3 Product Portfolio 8.8.4 Business Strategies 8.9 St. Jude Medical, Inc. 8.9.1 Company Overview 8.9.2 Financial Overview 8.9.3 Product Portfolio 8.9.4 Business Strategies 8.10 Johnson and Johnson Ltd 8.10.1 Company Overview 8.10.2 Financial Overview 8.10.3 Product Portfolio 8.10.4 Business Strategies About Us: Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
  9. 9. Contact: Transparency Market Research 90 State Street, Suite 700, Albany,NY – 12207, United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/ Browse the full report with Complete TOC at http://www.transparencymarketresearch.com/atrial-fibrillation-market.html

×